Atlas Trials

Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye

Clinical trial NCT00560638 · COMPLETED

Trial details

NCT number
NCT00560638
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye
Start date
2005-11-01
Primary completion
2006-02-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.